MACO-355

N/A

Report date: 2024/06/06 14:45:23
First In Class

Base Information

Drug NameMACO-355
Drug Alias NameMACO-355
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-LILRB
TargetsLeukocyte immunoglobulin-like receptor subfamily B
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMacomics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMacomics Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A